A CASE OF ANTRAL GASTRITIS , CHRONIC

BRONCHIAL ASTHAMA

A MALE PATIENT AGED 60 YEARS WAS ADMITTED ON

12-8-17 WITH THE COMPLAIN OF FEVER,STOMACH
DISCOMFORT, BREATHLESSNESS AND COUGH SINCE
4 DAYS , AND WAS DISCHARGED ON 17-8-17
 Name : ZYXABC

Age :60

Sex : male
PATIENT
DEMOGRAPHICS
IP number :17/1748

DOA :12/08/17

DOD : 17/08/17
 SUBJECTIVE EVIDENCE

• PATIENT COMPLAINED FOR SUFFERING FORM STOMACH PAIN AND IRRITATION

• THE PATIENT COMPLAINED FEVER AND COUGH SINCE 4 DAYS
• SHORTNESS OF BREATH
• WHEEZING AND TIGHTNESS IN CHEST WHILE BREATHING IN AND OUT
OBJECTIVE EVIDENCE
• General physical examination
P I C C L E

−− −− −− −− −− −−

• VITAL SIGNS:
DAY 1 DAY 2 DAY 3 DAY 4 DAY 5
TEMPERATURE 100 99 100 98.6 97
BP 130/80 120/80 125/85 120/80 120/80
PULSE 110 100 95 100 100
RR 18 18 18 18 18
ESR 20mm/hr −− 20mm/hr −− 20mm/hr
 OBJECTIVE EVIDENCE

• By the SUBJECTIVE Evidence and laboratory Investigation Patient was

found to be suffering from Antral Gastritis , Chronic Bronchial Asthama
 ASSESSMENT

• Diagnosis :
• With all Subjective and objective Evidence and laboratory investigations ,
patient is suffering from Antral Gastritis ,Chronic Bronchial Asthama

• THERAPEUTIC GOAL :
• To Reduce Breathing Problems, To reduce Fever, To treat Stomach irritation
and Discomfort
• Treatment of Chronic Bronchial Asthama , Antral Bronchitis
 PLANNING:
TREATMENT CHART
Sl DRUGS DOSE ROUTE Date started Date stopped
No: GENERIC NAME TRADE NAME
1 Omeprazole Inj .Acid 40 mg IV (parenteral) 12-08-17 17-08-17

2 Ondansetron Inj Emeset 08 mg IV (parenteral) 12-08-17 17-08-17

3 Chlorpheniramine Tab.Wikeryl 40 mg ORAL 12-08-17 17-08-17

4 Ramipril Cap.Ramance 05 mg ORAL 12-08-17 17-08-17

5 Salbutamol Asthalin 05 mg , Inhalation 12-08-17 17-08-17

Nebuliser B.D
6 Amlodipine Amlokand 40 mg ORAL 12-08-17 17-08-17

7 Cefuroxime Tab.ceftum 02 mg ORAL 12-08-17 17-08-17

 DRUG INTERACTION CHART
SL INTERACTING- DRUGS SEVERITY OF EFFECTS CLINICAL
NO INTERACTION MANAGEMENT
1. Chlorpheniramine   Moderate Alcohol may increase the Physician should advice
food nervous system side effect of patient about
chlorpheniramine and cause chlorpheniramine
dizziness , drowsiness and reaction with alcohol
difficulty in concentrating and strictly advice
patient to avoid its
consumption

2. Chlorpheniramine   Minor Salbutamol and Adjustment in dose

Salbutamol chlorphenamine may cause Interval
sedation in patients
3. Omeprazone  Moderate Co administration of these Adjustment in dose
Ondansetron drugs may effect the Hepatic Interval
Enzyme Metabolism
IMPORTANT PLANNING POINTS TO
PHYSICIAN

• As Salbutamol and chlorphenamine may cause sedation in patients physician

can separate the time of andinistration of these drugs
• Physician should advice patient about chlorpheniramine reaction with alcohol
and strictly advice patient to avoid its consumption
• As Ondansetron and Omeprazole react and cause disturbance in Hepatic
Enzyme Metabolism the time gap between administration of these drugs can
be maintained
PATIENT COUNSELLING WITH THE TREATMENT..
 Life style modification :
 Avoid pollution and dust
 Always wear mask
 Cold water is strictly prohibited
 Avoid contaminated Food and Water
 medication counselling
 Always adhere to medication
 Keep extra doses of medication in medkit
 If any side effects are observed than consult prescriber , and if any dose skipped
also seek medical advice
THANKYOU